European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

5 EU fundings (€3,325,497): Doctoral Training Network on Glycan–Cancer–Microbiota Interactions for Therapeutic and Diagnostic Innovation in Colorectal cancer … Bdl Year 2026 EU Research and Innovation programme "Horizon"

Text

Companies House 03009972

01/01/2026 EU funding (€15M): European Novel Drug research to Address Microbial infections and drug Resistance
27/03/2026 EU funding (€260,348): Decoding the role of dietary xenobiotic-active CAZymes in Ruminococcus gnavus: mechanisms, microbiome interactions, and health implications
20/07/2026 EU funding (€4,674,997): Doctoral Training Network on Glycan–Cancer–Microbiota Interactions for Therapeutic and Diagnostic Innovation in Colorectal cancer
19/05/2026 EU funding (€5,372,351): Improving Mental Health and Nutrition in Europe
29/06/2026 EU funding (€7,588,595): Biological evidence and mechanism-based disease classification for the improved diagnosis, prognosis and treatment of ME/CFS (DISCOVER-ME)

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Quadram Institute Bioscience, Norwich.

Printing is only available to North Data premium service subscribers.